SEC Form 4 · accession 0001144204-17-032195
Cytosorbents Corp · CTSO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael G. Bator
Director
Period of report
Jun 9, 2017
Accepted (ET)
Jun 12, 2017 · 6:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175151
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 9, 2017 | P | 1,500 | $4.12 | A | 70,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes (i) the following restricted stock units ("RSUs") that will be settled into common stock upon vesting upon a "Change In Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 6,000 RSUs granted on February 24, 2017 and (b) 60,000 RSUs granted on June 7, 2016 and (ii) 4,500 shares of common stock owned by the reporting person (including 1,500 shares of common stock purchased in the open market on June 9, 2017 and reported on this Form 4).